Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 12 Breast Neoplasms 7 Neoplasm Metastasis 5 Lymphoma 5 Multiple Myeloma 4 Leukemia 4 Hematologic Neoplasms 4 Colorectal Neoplasms 4 Prostatic Neoplasms 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Depression 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Ovarian Neoplasms 2 Motor Activity 2 Malignant Female Reproductive System Neoplasm 2 Glioblastoma 2 Fatigue 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Caregiver Burden 2 Anxiety Disorders 2 Advanced Malignant Solid Neoplasm 2 Thyroid Neoplasms 1 Stroke 1 Stress Disorders, Post-Traumatic 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Initiation and Maintenance Disorders 1 Signs and Symptoms 1

Interventions

bismuth tripotassium dicitrate 1 S 1 (combination) 1 Palliative Care 1 Oxaliplatin 1 Omeprazole 1 Clarithromycin 1 Amoxicillin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Chemotherapy Effect × Palliative Care × 1 year × Clear all

NCT05649852 2026-01-15

PASITHEA

GCS Ramsay Santé pour l'Enseignement et la Recherche

Phase NA Recruiting

Chemotherapy Effect

Data powered by HemOnc (CC BY 4.0) Colophon ⚡